HBM Healthcare Investments (Cayman) Ltd. 13D/13G Filings for ArriVent BioPharma, Inc. Common Stock (AVBP)

HBM Healthcare Investments (Cayman) Ltd. 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-15
4:07 pm
Purchase
2025-10-0813GARRIVENT BIOPHARMA INC
AVBP
HBM Healthcare Investments (Cayman) Ltd.2,195,014
5.400%
2,195,014increase
(New Position)
Filing